Neurolutions Revenue and Competitors
Estimated Revenue & Valuation
- Neurolutions's estimated annual revenue is currently $11.5M per year.
- Neurolutions's estimated revenue per employee is $251,000
Employee Data
- Neurolutions has 46 Employees.
- Neurolutions grew their employee count by 48% last year.
Neurolutions's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and Board Director | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Senior Director Engineering | Reveal Email/Phone |
4 | Clinical Relations Manager | Reveal Email/Phone |
5 | Clinical Manager | Reveal Email/Phone |
6 | Engineering Specialist | Reveal Email/Phone |
7 | Quality Engineer & Systems Specialist | Reveal Email/Phone |
Neurolutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $24.1M | 96 | 19% | N/A | N/A |
#2 | $9.5M | 38 | 12% | N/A | N/A |
#3 | $4M | 16 | -11% | N/A | N/A |
#4 | $7.8M | 31 | -3% | N/A | N/A |
#5 | $5M | 20 | -5% | N/A | N/A |
#6 | $49.9M | 199 | -8% | N/A | N/A |
#7 | $16.8M | 67 | -17% | $63.2M | N/A |
#8 | $9.3M | 37 | -7% | N/A | N/A |
#9 | $36.6M | 146 | 22% | N/A | N/A |
#10 | $64.3M | 205 | 3% | $502M | N/A |
What Is Neurolutions?
IpsiHand is an investigational medical device that is not available for sale. The IpsiHand utilizes brain-computer interface technology to facilitate rehabilitation and improve the brain-hand connection. The device is designed for stroke patients who have lost movement in their arm and hand.
keywords:N/AN/A
Total Funding
46
Number of Employees
$11.5M
Revenue (est)
48%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neurolutions News
2022-04-13 - 44 'breakthrough' medical devices that earned FDA approval
Neurolutions IpsiHand upper extremity rehabilitation system, manufactured by Neurolutions; Cognoa autism spectrum disorder diagnosis aid,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.3M | 46 | 10% | N/A |
#2 | $10.9M | 47 | 52% | N/A |
#3 | $3.5M | 48 | 14% | N/A |
#4 | $3.5M | 48 | 12% | N/A |
#5 | $10.4M | 48 | -8% | N/A |